Bevacizumab for recurrent ependymoma. [electronic resource]
Producer: 20091204Description: 1677-80 p. digitalISSN:- 1526-632X
- Adult
- Aged
- Angiogenesis Inhibitors -- administration & dosage
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Bevacizumab
- Brain Neoplasms -- drug therapy
- Disease Progression
- Drug Therapy, Combination
- Ependymoma -- drug therapy
- Female
- Follow-Up Studies
- Humans
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Retrospective Studies
- Time Factors
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.